MedPath

Assessment of Complications in Patients Who Underwent LPN According to the CCI

Completed
Conditions
Renal Cancer
Surgery-Complications
Registration Number
NCT05823545
Lead Sponsor
Samsun Liv Hospital
Brief Summary

This study aims to compare the strength of the classical Clavien-Dindo classification system (CDC), which is a Likert scale analysis versus the comprehensive complication index (CCI), a new quantitative evaluation system, in patients undergoing laparoscopic partial nephrectomy (LPN).

Detailed Description

Prospectively collected data of sixty-two patients undergoing LPN with postoperative complications from November 2009 to August 2020 were evaluated retrospectively. Postoperative complications were classified according to the CDCs and calculated using the CCI calculator (https://www.assessurgery.com) quantitatively. Major complications were determined as ≥ grade 3 complications according to the CDC. The complexity of the renal mass was defined according to the RENAL nephrometry score. The cut-off value for CCI was analyzed by the ROC analysis technique. The significance level was taken as p\<0.05.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
62
Inclusion Criteria
  • patients with complete data
  • patients with consent
  • Patients > 18 year-old
  • The surgeries performed by the surgeon EO
Exclusion Criteria
  • Missing data
  • patients without consent
  • patients who underwent open or retroperitoneoscopic laparoscopic partial nephrectomy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Opertaion timeduring the surgery (minute)

From first trocar incision to closure of all incisions

Estimeted blood lossduring the surgery (mL)

perioperative estimated blood loss

warm ischemia timeduring the surgery (minute)

Its starts when the renal artery and vein are controlled and it ends when reperfusion of the graft kidney starts on the back table

Postoperative complicationup to 3 months, postoperatively

Abnormal clinical and laboratory findings that may be seen after surgery and require additional intervention, treatment, or follow-up

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ondokuz Mayıs University, Department of Urology

🇹🇷

Samsun, Turkey

© Copyright 2025. All Rights Reserved by MedPath